Testosterone Cypionate Injection — Class III drug recall D-0242-2021
Terminated recall by SUN PHARMACEUTICAL INDUSTRIES INC, reported 2021-02-03, distributed nationwide. Incorrect Labeling: Incorrect lot number on secondary packaging
| Recall number | D-0242-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SUN PHARMACEUTICAL INDUSTRIES INC, Princeton, NJ, United States |
| Recall initiated | 2021-01-11 |
| Classified | 2021-01-24 |
| Reported by FDA | 2021-02-03 |
| Terminated | 2021-11-02 |
| Distributed | Nationwide (US) |
| Quantity | 36,275 cartons |
| Reason classes | labeling |
| NDC | 62756-0015, 62756-0015-40, 62756-0016, 62756-0016-40, 62756-0017, 62756-0017-40 |
| Lot numbers | JKX2553A |
Product
Testosterone Cypionate Injection, USP CIII 200mg/ml FOR INTRAMUSCULAR USE ONLY 1mL Single-dose vial Distributed by: Sun Pharma Ind. Inc, NJ 08512 Manufactured by: Sun Pharma Ind. Ltd., India NDC 62756-015-40
Reason for recall
Incorrect Labeling: Incorrect lot number on secondary packaging
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0242-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.